Better Coronavirus Stock: Sorrento Therapeutics vs. Vaxart

Many big drugmakers launched programs earlier this year to fight COVID-19. But the biggest winners for investors have been the stocks of small coronavirus-focused biotechs. Two that particularly stand out are Sorrento Therapeutics (NASDAQ: SRNE) and Vaxart (NASDAQ: VXRT).

Sorrento's shares have soared more than 140% year to date. Vaxart stock has skyrocketed more than 43 times higher so far in 2020. Which of these coronavirus stocks is the better pick now? Here's how Sorrento and Vaxart stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com